$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000031314324000007 Filed on February 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$343.3M	$336.3M
YoY Change		13.03%
Cost Of Revenue	$163.4M	$158.4M
YoY Change		13.47%
Gross Profit	$179.9M	$177.9M
YoY Change		12.64%
Gross Profit Margin	52.39%	52.9%
Selling, General & Admin	$111.8M	$111.7M
YoY Change		21.23%
% of Gross Profit	62.13%	62.81%
Research & Development	$15.74M	$13.27M
YoY Change		58.1%
% of Gross Profit	8.75%	7.46%
Depreciation & Amortization	$27.64M	$14.20M
YoY Change		-39.41%
% of Gross Profit	15.37%	7.98%
Operating Expenses	$137.9M	$131.9M
YoY Change		21.27%
Operating Profit	$41.94M	$45.98M
YoY Change		-6.45%
Interest Expense	-$6.529M	-$1.949M
YoY Change		-65.64%
% of Operating Profit	-15.57%	-4.24%
Other Income/Expense, Net		-$1.949M
YoY Change		84.74%
Pretax Income	$23.41M	$44.03M
YoY Change		7.23%
Income Tax	$3.047M	$12.80M
% Of Pretax Income	13.01%	29.07%
Net Earnings	$20.37M	$31.24M
YoY Change		-5.89%
Net Earnings / Revenue	5.93%	9.29%
Basic Earnings Per Share		$0.62
Diluted Earnings Per Share	$0.40	$0.61
COMMON SHARES
Basic Shares Outstanding	50.79M shares	50.74M shares
Diluted Shares Outstanding		51.45M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$178.8M	$194.0M
YoY Change		-19.58%
Cash & Equivalents	$178.8M	$194.0M
Short-Term Investments
Other Short-Term Assets	$66.34M	$55.37M
YoY Change		14.45%
Inventory	$317.2M	$304.0M
Prepaid Expenses
Receivables	$206.6M	$211.6M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$768.9M	$765.0M
YoY Change		6.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$311.4M	$318.7M
YoY Change		3.52%
Goodwill	$565.1M	$555.0M
YoY Change		19.07%
Intangibles	$406.1M	$429.3M
YoY Change		50.95%
Long-Term Investments
YoY Change
Other Assets	$136.4M	$127.4M
YoY Change		51.9%
Total Long-Term Assets	$1.427B	$1.435B
YoY Change		24.89%
TOTAL ASSETS
Total Short-Term Assets	$768.9M	$765.0M
Total Long-Term Assets	$1.427B	$1.435B
Total Assets	$2.196B	$2.200B
YoY Change		17.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.36M	$56.85M
YoY Change		-7.55%
Accrued Expenses	$80.71M	$58.76M
YoY Change		31.77%
Deferred Revenue	$31.24M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.23M	$13.74M
YoY Change		-76.4%
Total Short-Term Liabilities	$300.4M	$261.8M
YoY Change		-0.16%
LONG-TERM LIABILITIES
Long-Term Debt	$797.6M	$856.8M
YoY Change		12.81%
Other Long-Term Liabilities	$75.04M	$76.26M
YoY Change		-2.73%
Total Long-Term Liabilities	$872.6M	$933.1M
YoY Change		11.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$300.4M	$261.8M
Total Long-Term Liabilities	$872.6M	$933.1M
Total Liabilities	$1.173B	$1.195B
YoY Change		5.17%
SHAREHOLDERS EQUITY
Retained Earnings	$360.5M	$340.1M
YoY Change		51.98%
Common Stock	$635.1M	$627.6M
YoY Change		6.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$960.0M	$943.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.196B	$2.200B
YoY Change		17.98%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$20.37M	$31.24M
YoY Change		-5.89%
Depreciation, Depletion And Amortization	$27.64M	$14.20M
YoY Change		-39.41%
Cash From Operating Activities	$64.08M	-$530.0K
YoY Change		-100.61%
INVESTING ACTIVITIES
Capital Expenditures	$9.685M	$22.31M
YoY Change		-162.05%
Acquisitions
YoY Change
Other Investing Activities	-$3.371M	-$246.6M
YoY Change		-5144.43%
Cash From Investing Activities	-$13.06M	-$268.9M
YoY Change		765.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-63.50M	109.5M
YoY Change		-526.14%
NET CHANGE
Cash From Operating Activities	64.08M	-530.0K
Cash From Investing Activities	-13.06M	-268.9M
Cash From Financing Activities	-63.50M	109.5M
Net Change In Cash	-12.48M	-160.0M
YoY Change		-628.33%
FREE CASH FLOW
Cash From Operating Activities	$64.08M	-$530.0K
Capital Expenditures	$9.685M	$22.31M
Free Cash Flow	$54.40M	-$22.84M
YoY Change		-118.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44029000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	284466000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5725000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4932000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	211611000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	179142000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	304024000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	259379000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	55369000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46735000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	764982000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	769722000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	318665000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	310885000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	442810000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	417422000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	429270000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	275771000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	554999000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	466231000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	56845000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	627094000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	594706000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	340099000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30381000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	943319000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	817997000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2200428000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1934825000	usd
	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	10419000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	131889000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	115428000	usd
	us-gaap	Operating Expenses OperatingExpenses	380702000	usd
	us-gaap	Operating Expenses OperatingExpenses	338070000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	45978000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	43279000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	134940000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1949000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1055000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22759000	usd
	us-gaap	Net Income Loss NetIncomeLoss	97191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	86018000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.69
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.89
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50768000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50509000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50679000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50896000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51445000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51219000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51394000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51487000	shares
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	39564000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	37400000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	103190000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	76173000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193978000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5070000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5241000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127442000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106975000	usd
CY2023Q4	us-gaap	Assets Assets	2200428000	usd
CY2023Q2	us-gaap	Assets Assets	1934825000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13736000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	11784000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	63929000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	58762000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	64475000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	132412000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	111628000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	261755000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	251816000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	856849000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	754102000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	62246000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36195000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	76259000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	74715000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50785040	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50785040	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50448519	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50448519	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	508000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	504000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	253168000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24382000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	692000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	75000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6706000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	24908000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3187000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	893660000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2732000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	186000	usd
CY2023Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	40000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7217000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	31241000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8323000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	943319000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	749424000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2459000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	127000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5299000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	19877000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6763000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	770423000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2192000	usd
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	786000	shares
CY2022Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	75000000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5735000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	33197000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7538000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	729009000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1919000	usd
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	211000	shares
CY2022Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	160000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7491000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	32944000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	32944000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4456000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	775979000	usd
	us-gaap	Net Income Loss NetIncomeLoss	97191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	86018000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69576000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69453000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20912000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18525000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10419000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	94000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2393000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1098000	usd
	hae	Benefit Provision For Losses On Inventory BenefitProvisionForLossesOnInventory	-6904000	usd
	hae	Benefit Provision For Losses On Inventory BenefitProvisionForLossesOnInventory	-483000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2430000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	160000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27743000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24370000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	40721000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34506000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1730000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1970000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	15619000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10664000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4942000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16174000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	117670000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	193447000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56611000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	98272000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	243852000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2850000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	850000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1259000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7695000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	10129000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	318665000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	33205000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-309333000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125782000	usd
	hae	Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit	0	usd
	hae	Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit	280000000	usd
	hae	Decrease For Redemption Of Long Term Debt DecreaseForRedemptionOfLongTermDebt	0	usd
	hae	Decrease For Redemption Of Long Term Debt DecreaseForRedemptionOfLongTermDebt	280000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	110000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	50000000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	50000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8750000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7875000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1118000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	75000000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	849000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	21593000	usd
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	5603000	usd
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	4378000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1505000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2479000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5885000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	35000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-32000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	101659000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-98761000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-484000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4398000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-90488000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35494000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	284466000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	259496000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	193978000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	224002000	usd
	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	77946000	usd
	hae	Strategic Investments StrategicInvestments	7600000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	23500000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.86
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	31100000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	30200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4900000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25400000	usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	2150000	usd
	us-gaap	Restructuring Charges RestructuringCharges	8043000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1190000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	9003000	usd
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	7968000	usd
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	44000	usd
	us-gaap	Restructuring Charges RestructuringCharges	8043000	usd
	us-gaap	Restructuring Charges RestructuringCharges	165000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	9000000	usd
CY2023Q4	hae	Restructuring Charges Payable In Next Twelve Months RestructuringChargesPayableInNextTwelveMonths	8700000	usd
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	7968000	usd
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	44000	usd
	us-gaap	Restructuring Charges RestructuringCharges	8043000	usd
	us-gaap	Restructuring Charges RestructuringCharges	165000	usd
CY2023Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	2403000	usd
CY2022Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	4081000	usd
	hae	Restructuring Related Costs RestructuringRelatedCosts	6554000	usd
	hae	Restructuring Related Costs RestructuringRelatedCosts	10632000	usd
CY2023Q4	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	10371000	usd
CY2022Q4	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	4125000	usd
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	14597000	usd
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	10797000	usd
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	1100000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22800000	usd
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.209
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	31241000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	32944000	usd
	us-gaap	Net Income Loss NetIncomeLoss	97191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	86018000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50768000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50509000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50679000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50896000	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.69
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	31241000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	32944000	usd
	us-gaap	Net Income Loss NetIncomeLoss	97191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	86018000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50768000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50509000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50679000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50896000	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	677000	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	710000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	715000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	591000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51445000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51219000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51394000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51487000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.89
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2022Q3	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	75000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	225000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	135057000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	115016000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18374000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12572000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	150593000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	131791000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	304024000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	259379000	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	4300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	979291000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	944215000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	660626000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	633330000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	310885000	usd
	us-gaap	Depreciation Depreciation	41100000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	13100000	usd
	us-gaap	Depreciation Depreciation	37700000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	4300000	usd
	hae	Operating Lease Revenue As A Percentage Of Total Net Sales OperatingLeaseRevenueAsAPercentageOfTotalNetSales	0.03
CY2023Q2	us-gaap	Goodwill Goodwill	466231000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	87079000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1689000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	554999000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	850735000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	442810000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	407925000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	21345000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	672720000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	417422000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	255298000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	10400000	usd
CY2023Q4	hae	Number Of Interest Rate Swaps Remaining NumberOfInterestRateSwapsRemaining	2	segment
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5044000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2495000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4932000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2475000	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-653000	usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-224000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-833000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-429000	usd
CY2023Q4	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	-28000	usd
CY2022Q4	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	-19000	usd
	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	40000	usd
	hae	Accounts Receivable Allowance For Credit Loss Recovery Writeoff AccountsReceivableAllowanceForCreditLossRecoveryWriteoff	166000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5725000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2738000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5725000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2738000	usd
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-14865000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336250000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	8800000	usd
	us-gaap	Inventory Recall Expense InventoryRecallExpense	6800000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30381000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	8742000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	2743000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5999000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24382000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q4	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	332127000	usd
CY2022Q4	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	307290000	usd
	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	951469000	usd
	hae	Net Revenues By Business Unit Before Foreign Exchange Impact NetRevenuesByBusinessUnitBeforeForeignExchangeImpact	863191000	usd
CY2023Q4	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-1463000	usd
CY2022Q4	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-7361000	usd
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-2099000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305301000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	965765000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	864244000	usd
CY2023Q4	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-401000	usd
CY2022Q4	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	3581000	usd
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-879000	usd
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	9775000	usd
CY2023Q4	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	6911000	usd
CY2022Q4	hae	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	8078000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	21606000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24666000	usd
CY2023Q4	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	4869000	usd
CY2022Q4	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	287000	usd
	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	7768000	usd
	hae	Operating Expenses Transaction Costs OperatingExpensesTransactionCosts	-425000	usd
CY2023Q4	us-gaap	Restructuring Costs RestructuringCosts	-7968000	usd
CY2022Q4	us-gaap	Restructuring Costs RestructuringCosts	-44000	usd
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	8043000	usd
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	165000	usd
CY2023Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	2403000	usd
CY2022Q4	hae	Restructuring Related Costs RestructuringRelatedCosts	4081000	usd
	hae	Restructuring Related Costs RestructuringRelatedCosts	6554000	usd
	hae	Restructuring Related Costs RestructuringRelatedCosts	10632000	usd
CY2023Q4	hae	Digital Transformation Costs DigitalTransformationCosts	3415000	usd
CY2022Q4	hae	Digital Transformation Costs DigitalTransformationCosts	0	usd
	hae	Digital Transformation Costs DigitalTransformationCosts	10712000	usd
	hae	Digital Transformation Costs DigitalTransformationCosts	0	usd
CY2023Q4	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	-210000	usd
CY2022Q4	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	2000	usd
	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	621000	usd
	hae	Impairment Of Assets And Pcs2 Related Charges Credits ImpairmentOfAssetsAndPCS2RelatedChargesCredits	269000	usd
CY2023Q4	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	1433000	usd
CY2022Q4	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	2483000	usd
	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	4587000	usd
	hae	European Medical Device Regulation Costs EuropeanMedicalDeviceRegulationCosts	8175000	usd
CY2023Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	177000	usd
CY2022Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	757000	usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	6684000	usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1151000	usd
CY2023Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	10419000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	382000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	45978000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	43279000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	134940000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	120778000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336250000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305301000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	965765000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	864244000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336250000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305301000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	965765000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	864244000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true

Files In Submission

Name	View Source	Status
hae-20231230_cal.xml	Edgar Link	unprocessable
hae-20231230_def.xml	Edgar Link	unprocessable
0000313143-24-000007-index-headers.html	Edgar Link	pending
0000313143-24-000007-index.html	Edgar Link	pending
0000313143-24-000007.txt	Edgar Link	pending
0000313143-24-000007-xbrl.zip	Edgar Link	pending
ex103-haefy24q310xq.htm	Edgar Link	pending
ex104-haefy24q310xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hae-20231230.htm	Edgar Link	pending
hae-20231230.xsd	Edgar Link	pending
haefy24q3decex311.htm	Edgar Link	pending
haefy24q3decex312.htm	Edgar Link	pending
haefy24q3decex321.htm	Edgar Link	pending
haefy24q3decex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hae-20231230_lab.xml	Edgar Link	unprocessable
hae-20231230_pre.xml	Edgar Link	unprocessable
hae-20231230_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2024 Q1 Form 10-Q Financial Statement

#000031314324000007 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2024 Q1 Form 10-Q Financial Statement

#000031314324000007 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae